Arbutus Biopharma (ABUS) EBITDA (2015 - 2026)
Arbutus Biopharma (ABUS) posted EBITDA of -$5.95 million for Q2 2026, compared with $1.5 million a year earlier.
Powered by 
Analysis
Arbutus Biopharma (ABUS) EBITDA (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Arbutus Biopharma was $155.82 million; for FY2025, it came in at -$37.76 million.
- In prior years, Arbutus Biopharma's EBITDA was -$74.92 million in FY2024, -$76.7 million in FY2023, -$64.03 million in FY2022 and -$71.72 million in FY2021.
- Quarterly EBITDA has run from a low of -$25.37 million in Q1 2025 to a high of $168.92 million in Q1 2026 over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Arbutus Biopharma | 826.41 Mn | 453.39 Mn | - | -5.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.95 Mn |
| Mar 31, 2026 | 168.92 Mn |
| Sep 30, 2025 | -8.65 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | -25.37 Mn |
| Sep 30, 2024 | -21.10 Mn |
| Jun 30, 2024 | -21.23 Mn |
| Mar 31, 2024 | -19.01 Mn |
| Sep 30, 2023 | -21.19 Mn |
| Jun 30, 2023 | -18.04 Mn |
| Mar 31, 2023 | -17.08 Mn |
| Sep 30, 2022 | -17.47 Mn |
| Jun 30, 2022 | -13.73 Mn |
| Mar 31, 2022 | -10.58 Mn |
| Dec 31, 2021 | -20.32 Mn |
| Sep 30, 2021 | -17.96 Mn |
| Jun 30, 2021 | -18.21 Mn |
| Mar 31, 2021 | -15.23 Mn |
| Dec 31, 2020 | -15.79 Mn |
| Sep 30, 2020 | -14.73 Mn |
API Access
Arbutus Biopharma EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();